种植体植入同期行侧向骨增量的疗效:系统评价与Meta分析
基线平均缺损高度5.1mm,再入路时降至0.9mm,平均缺损解决率81.3%。结论:侧向骨增量成功,屏障膜与植骨材料联合应用可获得最佳缺损高度降低。
要点
- 侧向骨增量是水平骨缺损种植同期处理的有效方法
- 屏障膜联合植骨材料较单用植骨材料或不用增量更利于缺损高度降低
- 联合治疗与对照相比缺损高度降低无显著差异
核心结论
- 侧向骨增量是一种成功的治疗方式,为达到最佳缺损高度降低,应联合使用屏障膜和植骨材料。
研究设计与样本
- 系统评价与Meta分析,纳入随机对照试验或控制性临床 trials,要求再入路评估缺损解决且每组至少5例患者。
主要发现
- 最常用干预为异种颗粒植骨材料(XE)联合可吸收胶原膜(CM)。
- 基线平均缺损高度5.1mm(范围2.4-7.8),再入路时降至平均0.9mm(范围0.2-2.2),平均缺损解决率81.3%(范围56.4%-97.1%)。
- CM+XE对照与各试验组联合数据相比,缺损高度降低无显著差异(n=11;WMD=-0.006mm;95%CI,-0.61,0.60;p=0.985)。
- 无任何侧向骨增量劣于膜与植骨材料联合(n=1;MD=-1.96mm;95%CI,-3.48,-0.44;p=0.011)。
- 缺乏植骨材料劣于植骨材料与膜联合(n=1;MD=-2.44mm;95%CI,-4.53,-0.35;p=0.022),且添加膜较单用植骨材料更有利(n=3;WMD=0.97mm;95%CI,0.31,1.64;p=0.004)。
临床怎么用
- 临床在水平骨缺损种植同期行侧向骨增量时,推荐联合使用屏障膜和植骨材料以优化缺损高度降低。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To analyse the evidence regarding the efficacy of lateral bone augmentation procedures in terms of defect resolution in cases of horizontal ridge deficiencies after implant placement. MATERIALS AND METHODS: Included studies met the following inclusion criteria: randomized controlled trials (RCTs) or controlled clinical trials (CCTs), re-entry procedure to assess defect resolution, minimum of 10 patients (5 per group). Meta-analyses were performed whenever possible, including subgroup analysis based on membranes and grafting materials. RESULTS: Twenty-eight publications (20 short-term, 8 follow-up studies) were included. The most often used type of intervention was a xenogeneic particulated grafting material (XE) and a resorbable collagen membrane (CM). The mean defect height at baseline amounted to 5.1 mm (range 2.4-7.8) and decreased to a mean of 0.9 mm (range 0.2-2.2) at re-entry, and the mean defect resolution was 81.3% (range 56.4%-97.1%). Defect height reduction was not significantly different using CM+XE as control treatment compared to the combined data of the respective test groups [n = 11; weighted mean difference (WMD) = -0.006 mm; 95% CI, -0.61, 0.60; p = 0.985]. The absence of any lateral bone augmentation was less favourable than the conjunction of a membrane and a bone grafting material (n = 1; MD = -1.96 mm; 95% CI, -3.48, -0.44; p = 0.011). The lack of a grafting material was less favourable than the conjunction of grafting material and membrane (n = 1; MD = -2.44 mm; 95% CI, -4.53, -0.35; p = 0.022), and the addition of a membrane compared to a grafting material alone was more favourable (n = 3; WMD = 0.97 mm; 95% CI, 0.31, 1.64; p = 0.004). CONCLUSIONS: Lateral bone augmentation is a successful treatment modality. For optimal defect height reduction, a barrier membrane and a grafting material should be combined.
引用
- Thoma DS, Bienz SP, Figuero E, et al. Efficacy of lateral bone augmentation performed simultaneously with dental implant placement: A systematic review and meta-analysis. J Clin Periodontol. 2019. PMID: 30675733. doi:10.1111/jcpe.13050
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。